Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenerative Medical Technology (RMTG) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Regenerative Medical Technology (RMTG) over the last 7 years, with Q3 2025 value amounting to 0.01%.

  • Regenerative Medical Technology's Return on Capital Employed changed 0.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.0% for FY2024, which is 500.0% down from last year.
  • According to the latest figures from Q3 2025, Regenerative Medical Technology's Return on Capital Employed is 0.01%, which was down 0.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Return on Capital Employed ranged from a high of 0.94% in Q1 2021 and a low of 3.1% during Q2 2022
  • Moreover, its 5-year median value for Return on Capital Employed was 0.01% (2025), whereas its average is 0.36%.
  • Per our database at Business Quant, Regenerative Medical Technology's Return on Capital Employed plummeted by -33400bps in 2022 and then surged by 36300bps in 2023.
  • Over the past 5 years, Regenerative Medical Technology's Return on Capital Employed (Quarter) stood at 1.11% in 2021, then soared by 183bps to 0.92% in 2022, then plummeted by -96bps to 0.04% in 2023, then crashed by -109bps to 0.0% in 2024, then soared by 542bps to 0.01% in 2025.
  • Its Return on Capital Employed stands at 0.01% for Q3 2025, versus 0.01% for Q2 2025 and 0.01% for Q1 2025.